Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.

British Journal of Clinical Pharmacology

Volumn 32, Issue 5, 1991, Pages 624-626

  Back, DJ ^a   Tjia, JF ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ADULT; ARTICLE; DRUG METABOLISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; LIVER MICROSOME; MALE; PRIORITY JOURNAL;

ADULT; ANTIFUNGAL AGENTS; COMPARATIVE STUDY; CYCLOSPORINE; FEMALE; FLUCONAZOLE; HUMAN; ITRACONAZOLE; KETOCONAZOLE; MALE; MICROSOMES, LIVER; NAPHTHALENES;

EID: 0025949455     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1991.tb03963.x     Document Type: Article

References (26)

1. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro
2. Inhibition of the metabolism of cyclosporine in human liver microsomes by FK506
3. Cyclosporine, A. A clinical evaluation of drug interactions
4. Ketoconazole and cyclosporin
5. Ketoconazole, cyclosporine metabolism and renal transplantation
6. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients
7. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients
8. Concomitent cyclosporin and ketoconazole
9. Itraconazole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycoses
10. Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
11. Fluconazole‐cyclosporine interaction
12. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy
13. Cyclosprine metabolism in human liver. Identification of a cytochrome P‐450 III gene family as the major cyclosporine‐metabolizing enzyme explains interactions of cyclosporine with other drugs
14. Interaction of cyclosporine and itraconazole
15. Drug interactions with fluconazole
16. Protein measurement with the folin phenol reagent
17. Cyclosporin toxicity at therapeutic blood levels and cytochrome P450 IIIA
18. The carbonmonoxide binding pigment of liver microsomes
19. The metabolism of 17α‐ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites
20. The interaction of representative members from two classes of antimycotics—the azoles and the allylamines with cytochromes P‐450 in steroidogenic tissue and liver
21. Antipyrine metabolism is not affected by terbinafine, a new antifungal agent
22. Interaction of fluconazole and cyclosporine
23. Time course of cyclosporin itraconazole interactions
24. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis
25. Biochemical effects of miconazole on fungi II. Inhibition of ergosterol biosynthesis in
26. Pharmacokinetic drug interactions with cyclosporin (Part I)